Investigator
Pankaj Kapahi
BUCK INSTITUTE FOR RESEARCH ON AGING · funded by NIA
- Companies
- 3
- Grants
- 5
- Non-dilutive funding
- $2.5M
- First award
- May 1, 2018
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Feb 1, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
NeuroGrant-only
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
Grant-only
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Role of OXR1 and the retromer in brain aging and Alzheimer's disease and related dementias
$809kFeb 1, 2026NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11214362 (opens the source filing in a new tab)
- R01
The role of diet and aging in photoreceptor homeostasis and visual function decline
$731kJul 1, 2024NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11125803 (opens the source filing in a new tab)
- R01
The role of diet and aging in photoreceptor homeostasis and visual function decline
$745kJul 1, 2024NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11365097 (opens the source filing in a new tab)
- R13
Summer Training Course in Experimental Aging
$101kMay 1, 2018NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11167372 (opens the source filing in a new tab)
- R13
Summer Training Course in Experimental Aging
$100kMay 1, 2018NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11325884 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources